Saliva_ a Diagnostic Biomarker of Periodontal Diseases

6/13/13 Saliva: A diagnostic biomarker of periodontal diseases

www.ncbi.nlm.nih.gov/pmc/articles/PMC3283925/?report=printable 1/15

J Indian Soc Periodontol. 2011 Oct-Dec; 15(4): 310–317.

doi: 10.4103/0972-124X.92560

PMCID: PMC3283925

Saliva: A diagnostic biomarker of periodontal diseases

Priti Basgauda Patil and Basgauda Ramesh Patil

Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre, Maharashtra, India

Department of Pediatric and Preventive Dentistry, Dr. D.Y. Patil Dental College and Hospital, Maharashtra, India

Address for correspondence: Dr. Priti Basgauda Patil, Department of Periodontology, Tatyasaheb Kore Dental College and Research

Centre, New Pargaon - 417 137, Kolhapur, Maharashtra, India. E-mail: [email protected]

Received December 6, 2010; Accepted November 11, 2011.

Copyright : © Journal of Indian Society of Periodontology

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, w hich

permits unrestricted use, distribution, and reproduction in any medium, provided the original w ork is properly cited.

Abstract

Early detection of disease plays a crucial role in successful therapy. Early diagnosis and management

reduces the severity and possible complications of the disease process. To overcome this challenge,

medical researchers are devoted to finding molecular disease biomarkers that reveal a hidden lethal

threat before the disease becomes complicated. Saliva, an important physiologic fluid, containing a

highly complex mixture of substances, is rapidly gaining popularity as a diagnostic tool. Periodontal

disease is a chronic disease of the oral cavity comprising a group of inflammatory conditions affecting

the supporting structures of the dentition. In the field of periodontology, traditional clinical criteria are

often insufficient for determining sites of active disease, for monitoring the response to therapy, or for

measuring the degree of susceptibility to future disease progression. Saliva, as a mirror of oral and

systemic health, is a valuable source for clinically relevant information because it contains biomarkers

specific for the unique physiologic aspects of periodontal diseases. This review highlights the various

potentials of saliva as a diagnostic biomarker for periodontal diseases.

Keywords: Biomarker, diagnostic fluid, periodontal diseases, saliva

INTRODUCTION

Early detection of disease plays a crucial role in successful therapy. In most cases, the earlier the disease

is diagnosed, the more likely it is to be successfully cured or well controlled. However, most systemic

diseases are not diagnosed until morbid symptoms become apparent in the late phase. To overcome this

challenge, medical researchers are devoted to finding molecular disease biomarkers that reveal a hidden

lethal threat before the disease becomes complicated.[1]

NEED FOR A NEW BIOMARKER

Currently, three major limitations have prevented people from recognizing the full potential of disease

detection, and have seriously hampered the development of clinical diagnostics, namely:

1. Lack of definitive molecular biomarkers for specific diseases;

2. Lack of an easy and inexpensive sampling method with minimal discomfort; and

3. Lack of an accurate, easy-to-use, and portable platform to facilitate early disease detection.

1

1

http://dx.doi.org/10.4103%2F0972-124X.92560

http://www.ncbi.nlm.nih.gov/pubmed/?term=Patil%20PB%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Patil%20BR%5Bauth%5D

mailto:[email protected]

http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283925/?report=printable#ref1



Saliva, an oral fluid that contains an abundance of proteins and genetic molecules and is readily

accessible via a totally noninvasive approach, has long been recognized as the potential solution to these

limitations.[1]

Saliva provides an easily available, noninvasive diagnostic medium for a rapidly widening range of

diseases and clinical situations.[2]

In the field of periodontology, traditional clinical criteria are often insufficient for determining sites of

active disease, for monitoring the response to therapy or for measuring the degree of susceptibility to

future disease progression. Saliva as a mirror of oral and systemic health is a valuable source for

clinically relevant information because it contains biomarkers specific for the unique physiological

aspects of periodontal diseases.

PERIODONTAL DISEASE

Periodontal disease is a chronic disease of the oral cavity comprising a group of inflammatory

conditions affecting the supporting structures of the dentition.[3,4] The natural history of periodontitis

follows a discontinuous pattern of exacerbation and remission characterized by disease activity and

inactivity.[5,6] Periodontitis is a multifactorial disease which is affected by both genetic and

environmental factors.[7]

Clinical parameters such as probing depth, attachment level, bleeding on probing, plaque index, and

radiographic assessment of alveolar bone loss provide information on the severity of periodontitis but

they do not measure disease activity, whereas microbiological tests, analysis of host response, and

genetic analyses have been proposed in an effort to monitor and identify patients at increased risk for

periodontitis.[6,8]

SALIVA AS A DIAGNOSTIC FLUID IN PERIODONTAL DISEASES

Proposed salivary diagnostic markers for periodontal diseases have included serum and salivary

molecules such as immunoglobulins, enzymes constituents of gingival crevicular fluid, bacterial

components or products, volatile compounds, and phenotypic markers, such as epithelial keratins.[2,8]

COLLECTION OF SALIVA

The fluid mostly collected for salivary diagnostic purpose is expectorated whole saliva, a mix composed

largely of the secretions from the major salivary glands along with the modest contributions from the

minor salivary glands and gingival crevicular fluid.

Unstimulated or resting saliva is usually collected by passive drooling into a graduated tube or

preweighed vial so that flow rate per unit time can be measured.[2]

When volume measurement is not required, saliva can be collected on cotton swabs, cotton rolls, gauze

or filter paper strips, then eluted or centrifuged or aspirated directly from the floor of the mouth with

plastic pipettes.[2]

When large volumes of saliva are required for analytical purposes, saliva is stimulated by a masticatory

or gustatory stimulus, expectorated and handled in a similar manner as the unstimulated fluid. Softened

paraffin wax or a washed rubber band are the usual masticatory stimuli and 2% citric acid applied

directly to the tongue is the standard gustatory stimulus.[2]

Many a times secretions from individual glands are preferred and this can be accomplished in a

noninvasive manner with suitable collecting devices. Parotid saliva is best collected with plastic

modifications of a single cup first introduced by Carlson and Crittenden in 1910. Now disposable and

individualized collectors have been introduced for this purpose. Submandibular–sublingual saliva can be

collected by customization of a basic plastic collector or by aspiration from the duct openings with

















Specific markers

Salivary enzymes

Salivary ions

Nonspecific markers

micropipettes [Figure 1].[2]

SALIVARY MARKERS OF PERIODONTAL DISEASES

The various salivary biomarkers are as follows.

Markers affecting the dental biofilm

Immunoglobulins (Ig) are important specific defense factors of saliva. The

predominant immunoglobulin in saliva is secretory IgA (sIgA), which is derived from plasma cells in

the salivary glands. Lesser amount of IgG and IgM are also found in saliva. IgA, IgG, and IgM

influence the oral microbiota by interfering with the bacterial adherence or by inhibiting bacterial

metabolism.[3,9] There are two subclasses of IgA: IgA1 and IgA2. IgA1 is predominant in serum while

IgA2 is found in higher concentrations in external secretions, that is, tears, saliva, and milk.[10]

Many studies have been attempted to determine a relationship between salivary levels of sIgA and

various forms of periodontal diseases. It was found that there was a positive correlation between the

severity of inflammation and IgA concentration.[11,12]

Specific immunoglobulins in saliva directed toward periodontal pathogens have also been examined for

their diagnostic potential. Eggert et al.[13] reported that saliva from treated periodontitis patients had

higher IgA and IgG levels to periodontal pathogens porphyromonas. gingivalis and Treponema.

denticola than as compared to saliva from control subjects. Sandholm et al.[14] found increased

concentrations of salivary IgG to Aggregatibacter. actinomycetemcomitans in patients of aggressive

periodontitis.

Salivary enzymes can be produced by salivary glands, oral microorganisms,

polymorphonuclear leukocytes, oral epithelial cells derived from gingival crevicular fluid (GCF).

Lysozyme is an antimicrobial enzyme with the ability to cleave chemical bonds in the bacterial cell

wall. It can lyse some bacterial species by hydrolyzing glycosidic linkages in the cell wall peptidoglycan.

It may also cause lysis of bacterial cells by interacting with monovalent anions and with proteases

found in saliva. This combination leads to destabilization of the cell membrane, probably as a result of

the activation and deregulation of endogenous bacterial autolysins. Patients with low levels of lysozyme

in saliva are more susceptible to plaque accumulation, which is considered a risk factor for periodontal

disease.[15]

Peroxidase is a salivary enzyme produced by acinar cells in the salivary glands. This enzyme removes

toxic hydrogen peroxide produced by oral microorganisms and reduces acid production in the dental

biofilm, thereby decreasing plaque accumulation and the establishment of gingivitis and caries. Patients

with periodontal disease have demonstrated high levels of this enzyme in saliva.[16]

Calcium (Ca) is the ion that has been most intensely studied as a potential marker for

periodontal disease in saliva. Sewon et al.[17] reported a higher concentration of Ca detected in whole

stimulated saliva from the periodontitis patients. The authors concluded that an elevated Ca

concentration in saliva was characteristic of patients with periodontitis.

Nevertheless, the importance of the salivary Ca concentration in relationship to progression of

periodontal disease is not defined. Considering the distribution of Ca, this ion appears to hold only

limited promise as a marker for periodontal disease.[8]

Other proteins: A number of studies have examined the correlation between

nonenzymatic, nonimmunoglobulin proteins in saliva and periodontal disease.

Mucins are glycoproteins produced by submandibular and sublingual salivary glands and numerous

minor salivary glands. The physiological functions of the mucins (MG1 and MG2) are cytoprotection,

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283925/figure/F1/















Growth factors

Epithelial keratins

lubrication, protection against dehydration, and maintenance of viscoelasticity in secretions. The mucin,

MG2, affects the aggregation and adherence of bacteria and is known to interact with A.

actinomycetemcomitans, and a decreased concentration of MG2 in saliva may increase colonization

with this periodontopathogen.[3]

Lactoferrin is an iron-binding glycoprotein produced by salivary glands, which inhibits microbial

growth by sequestering iron from the environment, thus depriving bacteria of this essential element.

Lactoferrin is strongly upregulated in mucosal secretions during gingival inflammation and is detected

at a high concentration in saliva of patients with periodontal disease compared with healthy patients.

[18]

Histatin is a salivary protein with antimicrobial properties and is secreted from parotid and

submandibular glands. It neutralizes the endotoxic lipopolysaccharides located in the membrane of

gram-negative bacteria. Histatin is also an inhibitor of host and bacterial enzymes involved in the

destruction of the periodontium. In addition to its antimicrobial activities, histatin is involved in the

inhibition of the release of histamine from mast cells, affecting their role in oral inflammation.[3,19]

Fibronectin is a glycoprotein that promotes selective adhesion and colonization of certain bacterial

species while inhibiting others. It mediates adhesion between cells and is also involved in chemotaxis,

migration, inflammation, and wound healing and tissue repair.[8]

Cystatins (cysteine proteinases) are proteolytic enzymes originated from pathogenic bacteria,

inflammatory cells, osteoclasts, and fibroblasts. These enzymes have collagenolytic activity, which may

cause tissue destruction.[8] Cystatins are physiological inhibitors of cysteine proteinases, and may

function by modulating enzyme activity in the periodontium.

Cystatins are present in a variety of tissues and body fluids, including saliva. Cystatins were found in

saliva collected from the submandibular and sublingual salivary glands, and to a lesser degree in saliva

from the parotid gland.[20]

Platelet activating factor (PAF) is a potent phospholipid mediator of inflammation. Garito et al. found a

positive correlation between PAF and periodontal inflammation.[21] Various other studies also showed

similar findings but none of the authors discussed the potential diagnostic significance of their findings.

[8]

Amino acids Several studies have examined the levels of free amino acids in saliva in relation to

periodontal status. It appears that in some patients, elevated levels of certain amino acids, especially

proline, may be detected.[22,23] These amino acids probably appear in whole saliva as a result of

bacterial metabolism or degradation of salivary proteins rich in proline. In another study, by the same

investigators, no differences in amino acid concentrations in saliva were found between patients with

progressive periodontitis and controls. The authors concluded that levels of amino acids in oral fluids

(including GCF) has no diagnostic significance for periodontal disease.[24]

Epidermal growth factor (EGF) is involved in oral wound healing and functions with

hormone-like properties to stimulate epithelial cells. In humans, the parotid gland is the major source of

EGF.[8]

Vascular endothelial growth factor (VEGF), also known as vascular permeability factor or

vasculotropin, is a multifunctional angiogenic cytokine important in inflammation and wound healing.

This cytokine was found to be a component of whole saliva. Higher levels of VEGF were detected in

whole saliva from periodontitis patients.[8]

Epithelial cells from the lining of the oral cavity are found in saliva, but the

contribution of crevicular or pocket epithelial cells to the total number of salivary epithelial cells is not

known.[25] Furthermore, detection of keratins by monoclonal antibodies may have diagnostic value in


















Hormones

Inflammatory cells

Bacteria

Volatiles

the detection of epithelial dysplasia, oral cancer, odontogenic cysts, and tumors.[26]

It has been suggested that phenotypic markers for junctional and oral sulcular epithelia might

eventually be used as indicators of periodontal disease, however, there are no studies that demonstrate

an association between number or type of epithelial cells or specific types of keratins in saliva and

progression of periodontitis.[8]

Cortisol: Recent studies have suggested that emotional stress is a risk factor for periodontitis.

[7,27,28] One mechanism proposed to account for the relationship is that elevated serum cortisol levels

associated with emotional stress exert a strong inhibitory effect on the inflammatory process and

immune response.[29] The presence of cortisol in saliva has been recognized for more than 40 years.

[30] Recently, salivary cortisol levels were used to evaluate the role of emotional stress in periodontal

disease. Higher salivary cortisol levels were detected in individuals exhibiting severe periodontitis, a high

level of financial strain, and high emotion focused coping, as compared to individuals with little or no

periodontal disease, low financial strain, and low levels of emotion-focused coping.[31] While it appears

that emotional stress, as reflected by salivary cortisol levels, is a risk factor for periodontal disease,

attempts to diagnose periodontal disease severity or activity based on salivary cortisol levels are

premature. It can be argued that in addition to changes in the host response (ie, smoking, poor oral

hygiene, and poor compliance), stress also leads to behavioral changes, which could have a significant

effect on the periodontium. Additional studies are required to determine the diagnostic value of salivary

cortisol for periodontal disease.[8]

The number of leukocytes in saliva varies from person to person, and the cell counts

vary for an individual during the course of the day. The majority of salivary leukocytes enter the oral

cavity via the gingival crevice.[32] Klinkhammer[33] standardized collection and counting of leukocytes

in saliva and developed the orogranulocytic migratory rate (OMR). Raeste et al.,[34] in their study,

indicated that the OMR reflects the presence of oral inflammation, and suggested that this measure can

be used as a laboratory test.

Occult blood in saliva in relation to gingival inflammation has also been examined using a home-

screening test.[35]

Specific species of bacteria colonizing the subgingival environment have been implicated in the

pathogenesis of periodontal disease.[36–38] It has been suggested that microorganisms in dental plaque

can survive in saliva, and can utilize salivary components as a substrate. It was shown that saliva could

serve as a growth medium for oral Streptococus species and Actinomyces. viscous.[39]

In a study by De Jong et al.,[40] microorganisms from supragingival plaque were grown on saliva

agar. When supragingival plaque was plated on saliva and blood agar plates, the composition of the

microflora isolated from the plates were similar. The authors concluded that the supragingival

microflora could utilize saliva as a complete nutrient source. Studies have also shown the presence of

periodontopathic microorganisms, A. actinomycetemcomitans, P. gingivalis, Prevotella intermedia, and

T. denticola in whole saliva.[41,42]

An oral microbial rinse test (Oratest) was described by Rosenberg et al.[43] In this study Oratest was

found to be a simple method for estimating oral microbial levels. In a companion study, Oratest results

were correlated with plaque index and gingival index scores, and the authors stated that this test

provides a reliable estimate of gingival inflammation.[44]

Volatile sulfur compounds, primarily hydrogen sulfide and methylmercaptan, are associated

with oral malodor. Salivary volatiles have been suggested as possible diagnostic markers and

contributory factors in periodontal disease.

In a study of self-estimation of oral malodor, estimation of malodor based on saliva yielded a significant
























Markers in saliva via GCF

Markers of periodontal soft tissue inflammation

Markers of alveolar bone loss

correlation with objective parameters.[45]

As GCF traverses through inflamed periodontal tissues en route to the sulcus,

biological molecular markers are gathered from the surrounding areas and are subsequently eluted into

whole saliva.

Proinflammatory cytokines, such as prostaglandin E2

(PGE2), interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha are released from cells of the

junctional epithelium, connective tissue fibroblasts, macrophages, and polymorphonuclear leukocytes.

Enzymes, such as matrix metalloproteinase (MMP)-8, MMP-9, and MMP-13, produced by

polymorphonuclear leukocytes and osteoclasts, all lead to the degradation of connective tissue collagen

and alveolar bone. Studies have shown that PGE2 acts as a potent vasodilator and increases capillary

permeability, which elicits clinical signs of redness and edema. It also stimulates fibroblasts and

osteoclasts to increase the production of MMPs.[46]

Many different biomarkers associated with bone formation, resorption, and

turnover, such as alkaline phosphatase, osteocalcin, osteonectin, and collagen telopeptidases, have been

evaluated in GCF and saliva.[47] These mediators are associated with local bone metabolism as well as

with systemic conditions.

Matrix metalloproteinases (MMP): They are host proteinases responsible for both tissue degradation

and remodeling. During progressive periodontal breakdown, gingival and periodontal ligament

collagens are cleaved by host cell–derived interstitial collagenases.

MMP-8: It is the most prevalent MMP found in diseased periodontal tissue and GCF. Recently, the level

of MMP-8 was demonstrated to be highly elevated in saliva from patients with periodontal disease using

a rapid point-of-care microfluidic device.[48] Studies are required to evaluate MMP-8, either alone or in

conjunction with other molecular biomarkers, to predict the risk of future disease occurrence and to

monitor treatment interventions.

Gelatinase (MMP-9): Another member of the collagenase family, is produced by neutrophils and

degrades collagen intercellular ground substance. In their study, Teng et al.[49] found a twofold

increase in the mean MMP-9 levels in patients with progressive attachment loss. Given these results,

future use of MMP-9 in oral fluid diagnostics may serve as a guide in periodontal treatment monitoring.

Collagenase-3: Also referred to as MMP-13, is another collagenolytic MMP with an exceptionally wide

substrate specificity. In the future, MMP-13 may be useful for diagnosing and monitoring the course of

periodontal disease as well as for tracking the efficacy of therapy.[50]

Telopeptide: Given the specificity and sensitivity for bone resorption, pyridinoline cross-links, such as

pyridinoline cross-linked carboxyterminal telopeptide of type I collagen represent a potentially valuable

diagnostic aid for periodontal disease. Several investigations have explored the ability of pyridinoline

cross-links to detect bone resorption in periodontitis as well as in response to periodontal therapy.[51,52]

These studies assessing the role of GCF carboxyterminal telopeptide of type I collagen levels as a

diagnostic marker of periodontal disease activity have produced promising results to date.

Carboxyterminal telopeptide of type I collagen has been shown to be a promising predictor of both

future alveolar bone and attachment loss.

Controlled human longitudinal trials are needed to establish fully the role of salivary carboxyterminal

telopeptide of type I collagen as a predictor of periodontal tissue destruction, disease activity and

response to therapy in periodontal patients.

Osteocalcin: Elevated serum osteocalcin levels have been found during periods of rapid bone turnover,

such as in osteoporosis and multiple myeloma and during fracture repair. Therefore, studies have

investigated the relationship between GCF osteocalcin levels and periodontal disease.











Systemic markers

Oxidative stress marker

When a combination of the biochemical markers osteocalcin, collagenase, prostaglandin E2, alpha-2

macroglobulin, elastase, and alkaline phosphatase was evaluated, increased diagnostic sensitivity and

specificity values of 80% and 91%, respectively, were reported.[53]

Osteopontin: It is a single-chain polypeptide with a molecular weight of approximately 32,600. In bone

matrix, osteopontin is highly concentrated at sites where osteoclasts are attached to the underlying

mineral surface (ie, the clear zone attachment areas of the plasma membrane). Results from

periodontal studies indicated that osteopontin concentrations in GCF increased proportionally with the

progression of disease; and when nonsurgical periodontal treatment was provided, the osteopontin levels

in GCF were significantly reduced. Although additional long-term prospective studies are needed, at this

point osteopontin appears to hold promise as a possible salivary biomarker of periodontal disease

progression.[54]

C-reactive protein is produced by the liver and is stimulated by circulating

cytokines, such as tumor necrosis factor-alpha and interleukin-1, from local and/or systemic

inflammation such as periodontal inflammation. Circulating C-reactive protein may reach saliva via

GCF or the salivary glands. High levels of C-reactive protein have been associated with chronic and

aggressive periodontal diseases and with other inflammatory biomarkers.[19] C-reactive protein has

recently been shown to be measurable in saliva from periodontal patients using a lab-on-a-chip method.

[3]

Oxidative stress is defined as the result of an imbalance between oxidant factors

and protective antioxidant systems; it may occur due to an excess of free radicals, or by the diminishing

of the antioxidant systems. Oxidative stress is enhanced during periodontitis.[55] Oxidative stress can

result in DNA damage, including oxidation of nucleosides. 8-Hydroxydeoxyguanosine (8-OHdG) is an

oxidized nucleoside that is excreted in the bodily fluids with DNA repair. It has been demonstrated that

the 8-OHdG in bodily fluids can act as a biomarker of oxidative stress.[56]

Studies have shown that saliva is a biological product that can be easily collected and may be used for

the quantification of 8-OHdG as an oxidative stress biomarker in the diagnosis and monitorization of

the treatment in periodontitis.[57,58]

Antioxidative capacity of saliva

Physiologically free radical/reactive oxygen species in the mouth are derived mainly from

polymorphonuclear neutrophils (PMN), which may also help to control bacterial growth by the well-

known “respiratory burst” (RB). Such physiological processes are usually efficiently counteracted by

intrinsic antioxidant systems: if such systems fail, tissue damage can result.[59]

Saliva may constitute a first line of defence against free radical-mediated oxidative stress, since the

process of mastication promotes a variety of such reactions, including lipid peroxidation.[60] Moreover,

during gingival inflammation, gingival crevicular fluid (GCF) flow increases, adding to saliva with

products from the inflammatory response. This is why the antioxidant capacity of saliva is of increasing

interest.

Saliva is rich in antioxidants, mainly uric acid, with lesser contributions from albumin, ascorbate and

glutathione.[61] It has been reported that uric acid is the major antioxidant in saliva, accounting for

more than 85% of the total antioxidant activity of resting and stimulated saliva from both healthy and

periodontally compromised subjects.[61]

Antioxidants such as albumin, ascorbic acid, glutathione and traces of transferrin, lactoferrin, and

caeruloplasmin are also found in saliva.[59]

Emerging salivary diagnostic tools
















The use of saliva for translational and clinical application has emerged at the forefront. Most relevant to

periodontal diseases are the emerging toolboxes of the salivary proteome and the salivary transcriptome

for early detection, disease progression, and therapeutic monitoring. Using these emerging technologies,

it has been shown that salivary proteins and RNAs can be used to detect oral cancer[62,63] and

Sjogren's syndrome.[64] The stage is now poised to use these technologies for translational and clinical

applications in periodontal diseases.

Salivary proteome: The proteome is the protein complement of the genome, and proteomics is analysis

of the portion of the genome that is expressed. The proteomes in body fluids are valuable due to their

high clinical potential as sources of disease markers. In principle, a global analysis of the human

salivary proteomes can provide a comprehensive spectrum of oral and general health. Furthermore,

analysis of salivary proteomes over the course of complications may unveil morbidity signatures in the

early stage and monitor disease progression. Significant progress has been made in cataloguing human

saliva proteins and exploring their post-translational modifications. By using both two-dimensional gel

electrophoresis/mass spectrometry and “shotgun” proteomics approaches, Hu et al.[64,65] identified

309 distinct proteins in human whole saliva.

Collectively, 1166 salivary proteins have been identified: 914 from the parotid fluid and 917 from the

combined submandibular and sublingual fluids by Denny et al.[66]

Salivary transcriptome: Salivary transcriptome is an emerging concept. In addition to salivary

proteome, salivary transcriptomes (RNA molecules) were discovered that are unusually stable in saliva.

[67] They included mRNA molecules that cells use to convey the instructions carried by DNA for

subsequent protein production. This discovery presented a second diagnostic alphabet in saliva and

opened a door to another avenue of salivary transcriptomic diagnostics.[1]

Li et al.[67] found that RNA molecules elevated in oral cancer tissues are also elevated in saliva, which

prompted them to examine the scope and complexity of RNA present in human saliva. Other research

groups, particularly from forensic sciences, are focusing on multiplex mRNA profiling for the

identification of body fluids, including saliva.[68,69]

Possible testing for HIV

To expedite screening and accurately diagnose HIV infection, rapid point-of-care HIV tests have been

developed. Majority of these rapid tests utilize whole blood, plasma, and finger stick blood specimens,

whereas a few tests employ nonconventional specimens, such as saliva, oral mucosal fluid and urine.

[70,71] Although salivary and oral fluid-based tests have been in development for the past 20 years, it is

only recently that oral fluid-based, rapid point-of-care tests have increased in popularity.[71] Oral fluid

tests are based on a salivary component, the oral mucosal transudate or crevicular fluid, an interstitial

transudate rich in IgG antibodies, used for diagnosing HIV infection.[70–72] Although accuracy is very

high, oral fluid test results are considered preliminary. Therefore, the results of oral fluid tests require

confirmatory testing with conventional tests, such as ELISA and/or western blot.[73]

DISCUSSION

In the field of periodontal diagnosis, there has been a steady growing trend during the last 2 decades to

develop tools to monitor periodontitis. Currently, diagnosis of periodontal disease relies primarily on

clinical and radiographic parameters. These measures are useful in detecting evidence of past disease, or

verifying periodontal health, but provide only limited information about patients and sites at risk for

future periodontal breakdown. Numerous markers in saliva have been proposed and used as diagnostic

tests for periodontal disease.

Ideally, diagnostic tests should demonstrate high specificity and sensitivity. Given the complex nature of

periodontal disease, it is unlikely that a single marker will prove to be both sensitive and specific. A




















combination of two or more markers may provide a more accurate assessment of the periodontal

patient.

Interest in saliva as a diagnostic medium is escalating due to its many advantages over other diagnostic

biofluids. Both saliva and blood serum contain similar proteins and RNA, which is why saliva is

considered a “mirror to the body.”[74] Saliva is readily available which makes the collection process

fairly straightforward, even when multiple samples are needed. Its collection is noninvasive, which

makes the procedure more acceptable to patients and more conducive to a stress-free appointment.

Many of the hazards associated with blood collection do not apply to saliva. There is no potential for

cross-contamination among patients when used improperly and present a danger to health care

personnel. Because of the low concentrations of antigens in saliva, HIV, and hepatitis infections are

much less of a danger from saliva than from blood.[75] Saliva is also easier to handle because it does

not clot. As salivary testing becomes more commonplace, the costs could drop below those currently

incurred for urine/blood sampling. However, due to the uniqueness of the technique, the analysis today

is still quite expensive.

GCF has several diagnostic advantages, such as contributing inflammatory mediators and tissue-

destructive molecules associated with periodontitis that appear, and can be detected, in GCF. However,

GCF analyses are time consuming, requiring multiple sampling of individual tooth sites. The procedure

is labor intensive and somewhat technically demanding, requiring equipment for calibrating and

measuring fluid volumes. Finally, analysis is expensive, requires laboratory-based assays and generally

cannot be done chairside. In addition, GCF analyses involve miniscule amounts of fluid, often

approximately 1 μL, which has an impact on laboratory analysis, and can be contaminated with blood,

saliva, or plaque.[76] Given some of the problems inherent in sampling GCF, the analysis of salivary

biomarkers offers some advantages. Acquisition of saliva is easy, noninvasive, rapid, and requires less

manpower and materials than GCF. However, in contrast with GCF, whole saliva clearly provides

different diagnostic information.[77–79]

Because of the simple and noninvasive method of collection, salivary diagnostic tests appear to hold

promise for the future.

Novel technologies such as lab-on-a-chip and microfluidic devices have the potential to manage

complex oral fluids, such as saliva and GCF, and to provide a determination of a patient's periodontal

disease-risk profile, current disease activity, and response to therapeutic interventions. This approach

should accelerate clinical decision-making and monitoring of episodic disease progression in a chronic

infectious disease such as periodontitis.[8]

CONCLUSION

Saliva, like blood, contains an abundance of protein and nucleic acid molecules that reflects

physiological status; however, unlike other bodily fluids, salivary diagnostics offer an easy, inexpensive,

safe, and noninvasive approach for disease detection, and possess a high potential to revolutionize the

next generation of diagnostics.

Although challenges remain ahead, the use of saliva-based oral fluid diagnostics appear promising for

future application to diagnose periodontal diseases and to prognosticate periodontal treatment

outcomes.

ACKNOWLEDGMENTS

The authors would like to thank Dr. Hari Menon, Dr. Abhijit Gurav, and Dr. Abhijeet Shete for

thoughtful discussions, and assistance in preparation of the manuscript.

Footnotes









Source of Support: Nil

Conflict of Interest: None declared.

REFERENCES

1. Lee Y , Wong DT. Saliva: An emerging biofluid for early detection of disease. Am J Dent.

2009;22:241–8. [PMCID: PMC2860957] [PubMed: 19824562]

2. Mandel ID. The diagnostic uses of saliva. J Oral Pathol Med. 1990;19:119–25. [PubMed: 2187975]

3. Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT. Saliva as a diagnostic tool

for periodontal disease: Current state and future directions. Periodontol 2000. 2009;50:52–64.

[PubMed: 19388953]

4. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann

Periodontol. 1999;4:1–6. [PubMed: 10863370]

5. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol. 1996;1:821–78.

[PubMed: 9118282]

6. Sahingur SE, Cohen RE. Analysis of host responses and risk for disease progression. Periodontol

2000. 2004;34:57–83. [PubMed: 14717856]

7. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol. 1996;67(10

Suppl):1041–9. [PubMed: 8910821]

8. Kaufman I, Lamster IB. Analysis of saliva for periodontal diagnosis: A review. J Clin Periodontol.

2000;27:453–65. [PubMed: 10914885]

9. Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol

Molecular Biol Rev. 1998;62:71–109. [PMCID: PMC98907]

10. Delacroix DL, Dive C, Rambaud JC, Vaerman JP. IgA subclasses in various secretions and in serum.

Immunology. 1982;47:383–5. [PMCID: PMC1555453] [PubMed: 7118169]

11. Guven O, De Visscher JG. Salivary IgA in periodontal disease. J Periodontol. 1982;53:334–5.

[PubMed: 6953232]

12. Sandholm L, Gronblad E. Salivary immunoglobulins in patients with juvenile periodontitis and their

healthy siblings. J Periodontol. 1984;55:9–12. [PubMed: 6582264]

13. Eggert FM, Maenz L, Tam YC. Measuring the interaction of human secretory glycoproteins to oral

bacteria. J Dent Res. 1987;66:610–2. [PubMed: 3476577]

14. Sandholm L, Tolo K, Olsen I. Salivary IgG, a parameter of periodontal disease activity? High

responders to actinobacillus actinomycetemcomitans Y4 in juvenile and adult periodontitis. J Clin


15. Jalil RA, Ashley FP, Wilson RF, Wagaiyu EG. Concentrations of thiocyanate, hypothiocyanite, “free”

and “total” lysozyme, lactoferrin and secretory IgA in resting and stimulated whole saliva of children

aged 12-14 years and the relationship with plaque accumulation and gingivitis. J Periodont Res.

1993;28:130–6. [PubMed: 8478785]

16. Guven Y , Satman I, Dinccag N, Alptekin S. Salivary peroxidase activity in whole saliva of patients

with insulin-dependent (type-1) diabetes mellitus. J Clin Periodontol. 1996;23:879–81.

[PubMed: 8891941]

17. Sewon L, Karjalainen SM, Sainio M, Seppa O. Calcium and other salivary factors in periodontitis



affected subjects prior to treatment. J Clin Periodontol. 1995;22:267–70. [PubMed: 7622631]

18. Groenink J, Walgreen-Weterings E, Nazmi K, Bolscher JG, Veerman EC, van Winkelhoff AJ, et al.

Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated

periodontitis. J Clin Periodontol. 1999;26:269–75. [PubMed: 10355615]

19. Helmerhorst EJ, Oppenheim FG. Saliva: A dynamic proteome. J Dent Res. 2007;86:680–93.

[PubMed: 17652194]

20. Henskens YM, van der Velden U, Veerman ECI, Nieuw Amerongen AV. Cystatins S and C in

human whole saliva and in glandular salivas in periodontal health and disease. J Dent Res.

1994;73:1606–14. [PubMed: 7929975]

21. Garito ML, Prihoda TJ, McManus LM. Salivary PAF levels correlate with the severity of periodontal

inflammation. J Dental Res. 1995;74:1048–56.

22. Syrjanen S, Piironen P, Markkanen H. Free amino-acid composition of wax-stimulated whole saliva

in human subjects with healthy periodontium, severe chronic periodontitis and post-juvenile

periodontitis. Arch Oral Bio. 1984;29:735–8. [PubMed: 6594108]

23. Syrjanen S, Piironen P, Markkanen H. Free amino-acid content of wax stimulated whole saliva as

related to periodontal disease. Arch Oral Biol. 1987;32:607–10. [PubMed: 3481959]

24. Syrjanen S, Alakuijala L, Alakuijala P, Markkanen SO, Markkanen H. Free amino acid levels in oral

fluid of normal subjects and patients with periodontal disease. Arch Oral Biol. 1990;35:189–93.

[PubMed: 2190545]

25. Wilton JM, Curtis MA, Gillett IR, Griffiths GS, Maiden MF, Sterne JA, et al. Detection of high-risk

groups and individuals for periodontal diseases: Laboratory markers from analysis of saliva. J Clin


26. Morgan PR, Shirlaw PJ, Johnson NW, Leigh IM, Lane EB. Potential applications of anti-keratin

antibodies in oral diagnosis. J Oral Pathol. 1987;16:212–22. [PubMed: 2442335]

27. Linden GJ, Mullally BH, Freeman R. Stress and the progression of periodontal disease. J Clin


28. Axtelius B, Soderfeldt B, Nilsson A, Edwardsson S, Attstrom R. Therapy-resistant periodontitis.

Psychosocial characteristics. J Clin Periodontol. 1998;62:482–91. [PubMed: 9667482]

29. Chrousos GP, Gold PW. The concepts of stress and stress system disorders: Overview of physical and

behavioral homeostasis. J Am Med Assoc. 1992;267:1244–52.

30. Shannon IL, Prigmore JR, Brooks RA, Feller RP. The 17-hydroxycorticosteroids of parotid fluid,

serum and urine following intramuscular administration of repository corticotropin. J Clin Endocrinol.

1959;19:1477–80.

31. Genco RJ, Ho AW, Kopman J, Grossi SG, Dunford RG, Tedesco LA. Models to evaluate the role of

stress in periodontal disease. Ann Periodontol. 1998;3:288–302. [PubMed: 9722713]

32. Schiott RC, Loe H. The origin and variation in number of leukocytes in the human saliva. J

Periodont Res. 1970;5:36–41. [PubMed: 4255144]

33. Klinkhammer J. Quantitative evaluation of gingivitis and periodontal disease (I): The

orogranulocyte migratory rate. Periodontics. 1968;6:207–11. [PubMed: 5245876]

34. Raeste AM, Aura A. Rate of migration of oral leukocytes in-patients with periodontitis. Scand J Dent

Res. 1978;86:43–51. [PubMed: 273302]



35. Kopczyk RA, Graham R, Abrams H, Kaplan A, Matheny J, Jasper SJ. The feasibility and reliability

of using a home screening test to detect gingival inflammation. J Periodontol. 1995;66:52–4.

[PubMed: 7891250]

36. Genco RJ, Zambon JJ, Christersson LA. The role of specific bacteria in periodontal disease: The

origin of periodontal infections. Adv Dent Res. 1998;2:245–59. [PubMed: 3271019]

37. Socransky SS. Relationship of bacteria to the etiology of periodontal disease. J Dent Res.

1970;49:203–22. [PubMed: 4313844]

38. Slots J. Bacterial specificity in adult periodontitis: A summary of recent work. J Clin Periodontol.

1986;13:912–7. [PubMed: 3466908]

39. de Jong MH, van der Hoeven JS, van Os JH, Olijve JH. Growth of oral streptococcus species and

actinomyces viscosus in human saliva. App Environ Microbiol. 1984;47:901–4. [PMCID: PMC240009]

40. de Jong MH, van der Hoeven JS, van Os JH. Growth of micro-organisms from supragingival

dental plaque on saliva agar. J Dent Res. 1986;65:85–8. [PubMed: 3455973]

41. Asikainen S, Alaluusua S, Saxen L. Recovery of A.actinomycetemcomitans from teeth, tongue and

saliva. J Periodontol. 1991;62:203–6. [PubMed: 2027072]

42. Umeda M, Contreras A, Chen C, Bakker I, Slots J. The utility of whole saliva to detect the oral

presence of periodontopathic bacteria. J Periodontol. 1998;69:828–33. [PubMed: 9706862]

43. Rosenberg M, Barki M, Portnoy S. A simple method for estimating oral microbial levels. J Microbiol

Method. 1989;9:253.

44. Tal H, Rosenberg M. Estimation of dental plaque levels and gingival inflammation using a simple

oral rinse technique. J Periodontol. 1990;61:339–42. [PubMed: 2366142]

45. Rosenberg M, Kozlovsky A, Gelernter I, Cherniak O, Gabbay J, Baht R, et al. Self-estimation of oral

malodor. J Dent Res. 1995;74:1577–82. [PubMed: 7560419]

46. Airila-Mansson S, Soder B, Kari K, Meurman JH. Influence of combinations of bacteria on the levels

of prostaglandin E2, interleukin-1beta, and granulocyte elastase in gingival crevicular fluid and on the

severity of periodontal disease. J Periodontol. 2006;77:1025–31. [PubMed: 16734578]

47. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in

periodontitis. Ann N Y Acad Sci. 2007;1098:230–51. [PMCID: PMC2570328] [PubMed: 17435132]

48. Herr AE, Hatch AV, Throckmorton DJ, Tran HM, Brennan JS, Giannobile WV, et al. Microfluidic

immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci USA. 2007;104:5268–73.

[PMCID: PMC1828942] [PubMed: 17374724]

49. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to

periodontal disease in human subjects. J Periodontal Res. 1992;27:544–52. [PubMed: 1403585]

50. Hernandez M, Valenzuela MA, Lopez-Otin C, Alvarez J, Lopez JM, Vernal R, et al. Matrix

metalloproteinase- 13 is highly expressed in destructive periodontal disease activity. J Periodontol.

2006;77:863–70.

51. Giannobile WV. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue

destruction. Ann N Y Acad Sci. 1999;878:404–12. [PMCID: PMC2586930] [PubMed: 10415744]

52. Talonpoika JT, Hamalainen MM. Type I collagen carboxyterminal telopeptide in human gingival

crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol.

1994;21:320–6. [PubMed: 8034776]



53. Nakashima K, Giannopoulou C, Andersen E, Roehrich N, Brochut P, Dubrez B, et al. A longitudinal

study of various crevicular fluid components as markers of periodontal disease activity. J Clin


54. Sharma CG, Pradeep AR. Gingival crevicular fluid osteopontin levels in periodontal health and

disease. J Periodontol. 2006;77:1674–80. [PubMed: 17032109]

55. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in

whole saliva and evidence of increased protein oxidation. Clin Sci (Lond) 2003;105:167–72.

[PubMed: 12650638]

56. Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, et al. Immunohistochemical

evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal. 2004;6:19–24.

[PubMed: 14713333]

57. Badea V, Balaban D, Amariei C, Nuca C, Bucur L. Salivary 8-hidroxy-2-deoxy guanosine as

oxidative stress biomarker for the diagnosis of periodontal disease. Farmacia. 2010;58:5.

58. Takane M, Sugano N, Ezawa T, Uchiyama T, Ito K. A marker of oxidative stress in saliva:

Association with periodontally-involved teeth of a hopeless prognosis. J Oral Sci. 2005;47:53–7.

[PubMed: 15881229]

59. Battino M, Ferreiro MS, Gallardo I, Newman HN, Bullon P. The antioxidant capacity of saliva. J

Clin Periodontol. 2002;29:189–94. [PubMed: 11940135]

60. Terao J, Nagao A. Antioxidative effect of human saliva on lipid peroxidation. Agr Biol Chem.

1991;55:869–72.

61. Moore S, Calder KA, Miller NJ, Rice-Evans CA. Antioxidant activity of saliva and periodontal

disease. Free Radical Res. 1994;21:417–25. [PubMed: 7834056]

62. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral

cancer biomarker discovery. Clin Cancer Res. 2008;14:6246–52. [PMCID: PMC2877125]

[PubMed: 18829504]

63. Li Y , St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for

oral cancer detection. Clin Cancer Res. 2004;10:8442–50. [PubMed: 15623624]

64. Hu S, Wang J, Meijer J, Ieong S, Xie Y , Yu T, et al. Salivary proteomic and genomic biomarkers for

primary Sjogren's syndrome. Arthritis Rheum. 2007;56:3588–600. [PMCID: PMC2856841]

[PubMed: 17968930]

65. Hu S, Xie Y , Ramachandran P, Ogorzalek Loo RR, Li Y , Loo JA, et al. Large-scale identification of

proteins in human salivary proteome by liquid chromatography ⁄ mass spectrometry and two-

dimensional gel electrophoresis- mass spectrometry. Proteomics. 2005;5:1714–28. [PubMed: 15800970]

66. Denny P, Hagen FK, Hardt M, Liao L, Yan W, Arellanno M, et al. The proteomes of human parotid

and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res.

2008;7:1994–2006. [PMCID: PMC2839126] [PubMed: 18361515]

67. Li Y , Zhou X, St John MA, Wong DT. RNA profiling of cell free saliva using microarray technology.

J Dent Res. 2004;83:199–203. [PubMed: 14981119]

68. Ballantyne J. Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res.

2007;13:1350. author reply 1351. [PubMed: 17317848]

69. Nussbaumer C, Gharehbaghi-Schnell E, Korschineck I. Messenger RNA profiling: A novel method

for body fluid identification by Real-Time PCR. Forensic Sci Int. 2006;157:181–6. [PubMed: 16289614]



70. Gottfried TD, Mink RW, Phanuphak P. Calypte AWARE HIV-1/2 OMT antibody test using oral

fluid: Special challenges of rapid HIV testing in the developing world. Expert Rev Mol Diagn.

2006;6:139–44. [PubMed: 16512774]

71. Jones JP. In the culture of now: The arrival of the OraQuick rapid HIV test. Posit Aware.

2004;15:35–6. [PubMed: 15526392]

72. Donovan BJ, Rublein JC, Leone PA, Pilcher CD. HIV infection: Point-of-care testing. Ann

Pharmacother. 2004;38:670–6. [PubMed: 14990775]

73. Reynolds SJ, Muwonga J. OraQuick ADVANCE Rapid HIV-1/2 antibody test. Expert Rev Mol

Diagn. 2004;4:587–91. [PubMed: 15347252]

74. Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W. SELDI-TOF-MS of

saliva: Methodology and pre-treatment effects. J Chromatogr B Analyt Technol Biomed Life Sci.

2007;847:45–53.

75. Major CV, Read SE, Coates RA, Francis A, McLaughlin BJ, Millson M, et al. Comparison of saliva

and blood for human immunodeficiency virus prevalence testing. J Infect Dis. 1991;163:699–702.

[PubMed: 2010625]

76. Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontol 2000.

2003;31:32–42. [PubMed: 12656994]

77. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, et al. Current

developments in salivary diagnostics. Biomark Med. 2010;4:171–89. [PMCID: PMC2857781]

[PubMed: 20387312]

78. D’Aiuto F, Ready D, Tonetti MS. Periodontal disease and C reactive protein-associated

cardiovascular risk. J Periodontal Res. 2004;39:236–41. [PubMed: 15206916]

79. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to

periodontal disease in human subjects. J Periodontal Res. 1992;27:544–52. [PubMed: 1403585]

Figures and Tables

Figure 1



Biomarkers seen in saliva

Articles from Journal of Indian Society of Periodontology are provided here courtesy of Medknow Publications

Saliva_ a Diagnostic Biomarker of Periodontal Diseases

Documents